1. Market Research
  2. > Biotechnology Market Trends
  3. > Biological Therapy

How to kick-start your market research using the mechanical goods sector's key figures

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
0 vote

Global Biological Therapy Industry

The world biologics industry was worth almost $150 billion in 2010, according to research from BCC Research. The market is expected to record yearly growth of around 10% to reach almost $240 billion by 2015.

Market growth is fuelled by interest in biosimilars, the need to elaborate a superior drug pipeline, a move toward cost-reducing manufacturing technologies and appealing targets against challenging diseases.

Key Market Segments

The global gene therapy market is benefiting from increasing interest in the development of disease treatment. RNCOS notes that this market holds strong development potential as progress in the field of gene therapy facilitates research into the pathogenesis of diseases. This involves a move from research laboratories to clinical trials, which leads to greater potential for the biotechnology sector. Gene therapy market expansion is expected to be very strong over the coming years, fuelled by interest from biopharma companies focused on the area. Companies are expected to elaborate therapies for disease through on-site research and grow acquired therapies into commercial forms.

Gene therapy will prove vital to the medical industry to provide a disease-specific approach to developing treatments. The therapeutic applications of gene therapy are expanding to encompass areas like acquired diseases, including immunodeficiency syndromes. Growth is strong in the US, the EU, China, Japan and Canada. Cancer treatment is expected to represent the fastest-growing segment, followed by infectious diseases such as AIDS.

The global RNA Interference (RNAi) industry is expected to record 28% yearly growth for the five-year period ending 2015, reports RNCOS. Market growth will be fuelled by greater use of the expertise for functional genomics research, necessary for target validation, drug discovery and drug development. 

The worldwide market for cancer therapiesis expected to reach $225 billion by 2017, according to research from Global Industry Analysts. Market expansion will be fuelled by increasing numbers of cancer patients, adoption of new drugs and growing existing drugs. Market growth will also be driven by greater adoption of high-priced biologic therapies in cancer treatment. Medical treatment of cancer includes therapies such as chemotherapy, radiotherapy and gene therapy. The majority of cancer therapies are elaborated using hormones and cytokines, colony stimulating factors, monoclonal antibodies oncolytic viruses, cancer vaccines, antisense oligonucleotides and other approaches.

Leading companies in the sector include Takeda Pharmaceutical Company, GlaxoSmithKline, Eli Lilly, Amgen, Hoffmann-La Roche, Janssen Biotech, Sanofi-Aventis, AstraZeneca, Celgene Corporation, Novartis, Genentech and Bristol-Myers Squibb.

Regional Market Share

The US stem cell market is expected to record yearly growth of 45% between 2011 and 2013, reports RNCOS. The market has recorded strong growth over the past few years with massive investment despite the economic recession. Stem cell technologies and products are giving rise to breakthroughs in the treatment of diseases.

Read more »


You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 1 800 reports

The future of the Biological Therapy Industry in the US

  • October 2015
    7 pages
  • Biological Ther  

  • United States  

View report >

Biological Therapy Industry in Europe

  • January 2014
    70 pages
  • Biological Ther  

  • Europe  

View report >

Biological Therapy Industry in Asia

  • January 2014
    9 pages
  • Biological Ther  

  • Asia  


View report >

Biological Therapy Industry in Japan

  • July 2015
    10 pages
  • Biological Ther  


  • Japan  

View report >

Biological Therapy Industry in France

  • January 2014
    16 pages
  • Biological Ther  

  • France  

View report >

Biological Therapy Industry in Germany

  • January 2015
    14 pages
  • Biological Ther  

  • Germany  

View report >

Biological Therapy Industry in the US and Italy

  • January 2013
    7 pages
  • Biological Ther  


  • United States  


View report >

Biological Therapy Markets in the US and the UK

  • March 2015
    13 pages
  • Biological Ther  

  • United States  

    United Kingdom  

View report >

Biological Therapy Industry in Canada

  • September 2015
    9 pages
  • Biological Ther  

  • Canada  

View report >

Biological Therapy Industry in Brazil

  • December 2014
    8 pages
  • Biological Ther  

  • Brazil  

View report >

Search in Biological Therapy Industry (About 1 800 reports)
Parent industry: Biotechnology
Related industries: Biomaterial, Biopharmaceutical, Genetically Modified Organism, Genomics

About 900 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 6 650)

RNAi Technologies and Global Markets

RNAi Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2016
  • by BCC Research

This BCC Research report summarizes the global RNAi technologies market by category and by region. The RNAi market is analyzed based on RNAi research tools and reagents as well as on RNAi diagnostics. ...

Breast Cancer Therapeutics In Major Developed Markets T ...

December 2015 $ 4 995

Primary Immunodeficiency Diseases Market - Global Indus ...

November 2015 $ 4 795

Cell Analysis Market By Product, By Process, & By End U ...

January 2016 $ 4 650

Cell Isolation/cell Separation Market By Product, Cell ...

January 2016 $ 4 650

Immunotherapy Drugs Market By Type Of Drug, Checkpoint ...

December 2015 $ 4 650

Molecular Diagnostics Market By Application , Oncology, ...

November 2015 $ 4 650

European Nuclear Medicine/radiopharmaceuticals Market B ...

November 2015 $ 4 650

Bovine Fgf Chemical Report

February 2016 $ 4 609

3d Cell Culture Global Market – Forecast To 2021

January 2016 $ 4 500

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.